6-Methylnicotinamide is a nicotinamide derivative used in the preparation of co-crystals and salts for research. Studies indicate that elevated levels of this metabolite can exacerbate neurological damage during the acute phase of intracerebral hemorrhage (ICH), making it relevant for investigating related pathological mechanisms.
